Use of inactivated poliovirus vaccine for poliovirus outbreak response
- PMID: 38012892
- DOI: 10.1016/S1473-3099(23)00505-4
Use of inactivated poliovirus vaccine for poliovirus outbreak response
Erratum in
-
Correction to Lancet Infect Dis 2023; published online Nov 24. https://doi.org/10.1016/S1473-3099(23)00505-4.Lancet Infect Dis. 2024 Feb;24(2):e83. doi: 10.1016/S1473-3099(23)00760-0. Epub 2023 Dec 6. Lancet Infect Dis. 2024. PMID: 38070529 No abstract available.
Abstract
With continued wild poliovirus transmission in Afghanistan and Pakistan and circulating vaccine-derived poliovirus in certain countries, there exists an ongoing risk of importation of polioviruses into other countries, including those that have been polio-free for decades. Diversifying the poliovirus outbreak response toolkit is essential to account for different public health and epidemiological contexts. In this Personal View, we discuss data on intestinal and pharyngeal mucosal immunity induced by inactivated poliovirus vaccine (IPV), previous programmatic experience of poliovirus outbreak response with IPV, and outbreak response guidelines in countries that exclusively use IPV. With recent reports of poliovirus detection in polio-free countries such as the USA and the UK, it is important to assess the interplay of virus transmission dynamics, vaccine impact on preventing paralysis and virus spread, and regulatory complexities of using oral poliovirus vaccine (OPV) and IPV options for outbreak response. As the global eradication programme navigates through cessation of routine OPV use with replacement by IPV and stockpiling of novel OPVs, clarity on the impact of IPV use will be important for informed decision making by global, regional, and national policy makers.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Similar articles
-
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.Vaccine. 2024 Feb 6;42(4):819-827. doi: 10.1016/j.vaccine.2023.12.081. Epub 2024 Jan 12. Vaccine. 2024. PMID: 38218668 Free PMC article. Review.
-
Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses.Vaccine. 2015 Mar 24;33(13):1568-77. doi: 10.1016/j.vaccine.2015.02.013. Epub 2015 Feb 18. Vaccine. 2015. PMID: 25701673 Free PMC article.
-
Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.J Infect Dis. 2014 Nov 1;210 Suppl 1:S485-97. doi: 10.1093/infdis/jit838. J Infect Dis. 2014. PMID: 25316871
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2. Cochrane Database Syst Rev. 2019. PMID: 31801180 Free PMC article.
-
Polio endgame: the global switch from tOPV to bOPV.Expert Rev Vaccines. 2016 Jun;15(6):693-708. doi: 10.1586/14760584.2016.1140041. Epub 2016 Feb 2. Expert Rev Vaccines. 2016. PMID: 26751187 Review.
Cited by
-
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections.Vet Res. 2024 Sep 30;55(1):128. doi: 10.1186/s13567-024-01383-x. Vet Res. 2024. PMID: 39350170 Free PMC article. Review.
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article. Review.
-
The Last Mile in Polio Eradication: Program Challenges and Perseverance.Pathogens. 2024 Apr 15;13(4):323. doi: 10.3390/pathogens13040323. Pathogens. 2024. PMID: 38668278 Free PMC article. Review.
-
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency.Pathogens. 2024 Mar 23;13(4):273. doi: 10.3390/pathogens13040273. Pathogens. 2024. PMID: 38668228 Free PMC article. Review.
-
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance.Pathogens. 2024 Mar 4;13(3):224. doi: 10.3390/pathogens13030224. Pathogens. 2024. PMID: 38535567 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials